Soligenix: High Risk, High Reward
Seeking Alpha,
Soligenix is a small biotech company with just ~$20M market cap. In the near future, the company will complete two Phase 3…
Soligenix is a small biotech company with just ~$20M market cap. In the near future, the company will complete two Phase 3…
Skin-directed therapies play an important role in treating patients with early-stage cutaneous T-cell lymphoma (CTCL)/mycosis…